Molecular Technologies Labs, based in Athens, OH, is a forward-thinking and innovative contract research organization (CRO) specializing in early drug development, pre-clinical and clinical services, bioProduction, and diagnostics. With a team of expert scientists operating in multiple BSL Level II labs, including 33 PhDs and over 50 issued and pending patents, they partner with clients to maximize results and accelerate technology to market.
Offering a comprehensive range of services, Molecular Technologies Labs assists clients in assay development, protein biochemistry, genetic engineering, cell line development, GLP and non-GLP assay development and validation, pharmacokinetic analysis, toxicological support, immunogenicity testing, ADA analysis, gene therapy, biomarker testing, and more. They work with virtual and mid-size biotech companies, industry consulting firms, and pharmaceutical companies, providing a fully collaborative development process without requiring an equity position or IP ownership.
Generated from the website